| dc.contributor.author | Demirbaş, Abdullah | |
| dc.contributor.author | Elmas, Ömer F. | |
| dc.contributor.author | Türsen, Ümit | |
| dc.contributor.author | Atasoy, Mustafa | |
| dc.contributor.author | Lotti, Torello | |
| dc.date.accessioned | 2022-06-08T08:16:43Z | |
| dc.date.available | 2022-06-08T08:16:43Z | |
| dc.date.issued | 2020 | en_US |
| dc.identifier.citation | Demirbaş, A., Elmas, Ö. F., Türsen, Ü., Atasoy, M., & Lotti, T. (2020). Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D—Dimer. Dermatologic Therapy, 33(4), e13768. | en_US |
| dc.identifier.issn | 13960296 | |
| dc.identifier.uri | https://doi.org/10.1111/dth.13768 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12513/4488 | |
| dc.description.abstract | To The Editor,Coronavirus Disease 2019 (COVID-19)is a respiratory tract disease cau-sed by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2),which first appeared on December 1, 2019 in Wuhan, China. The pan-demic was declared by World Health Organization on March 11, 2020and as of May 21, 2020, more than 5 million cases were reported world-wide and more than 300 thousand deaths occurred... | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Blackwell Publishing Inc. | en_US |
| dc.relation.isversionof | 10.1111/dth.13768 | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D—Dimer | en_US |
| dc.type | article | en_US |
| dc.relation.journal | Dermatologic Therapy | en_US |
| dc.contributor.department | Tıp Fakültesi | en_US |
| dc.contributor.authorID | Ömer Faruk Elmas / 0000-0002-5474-6508 | en_US |
| dc.identifier.volume | 33 | en_US |
| dc.identifier.issue | 4 | en_US |
| dc.identifier.startpage | 1 | en_US |
| dc.identifier.endpage | 2 | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
